Both in Diagnostics
Idexx Laboratories vs Intellia Therapeutics
Over the past year IDXX returned −7.0% and NTLA returned −9.3%; their daily moves had a correlation of 0.06.
IDXX −7.0% NTLA −9.3%Growth of $1, one year, split-adjusted
| Metric | IDXX | NTLA |
|---|---|---|
| Price | $672.04 | $11.86 |
| Market cap | $52.94B | $1.66B |
| Today | +0.06% | +1.72% |
| 1 month | +27.5% | −7.0% |
| 6 months | +19.4% | −10.9% |
| Year to date | −0.7% | +31.9% |
| 1 year | +6.8% | −6.0% |
| Revenue growth (YoY) | +9.9% | −46.2% |
| Gross margin | 62.9% | 100.0% |
| Net margin | 26.1% | −1392.3% |
| P/E (TTM) | 44.8× | — |
| Price / sales | 11.4× | 27.9× |
| Net cash | -$651.3M | $437.8M |
| Dividend yield | — | — |
| Volatility (60d) | 48.0% | 62.6% |
| Short % of float | 2.5% | 38.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).